BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30936287)

  • 1. Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ Complication.
    Moinzadeh P; Kuhr K; Siegert E; Blank N; Sunderkoetter C; Henes J; Krusche M; Schmalzing M; Worm M; Schmeiser T; Günther C; Aberer E; Susok L; Riemekasten G; Kreuter A; Zeidler G; Juche A; Hadjiski D; Müller-Ladner U; Gaebelein-Wissing N; Distler JHW; Sárdy M; Krieg T; Hunzelmann N
    J Rheumatol; 2020 Feb; 47(2):241-248. PubMed ID: 30936287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DRB1*0407 and *1304 are risk factors for scleroderma renal crisis.
    Nguyen B; Mayes MD; Arnett FC; del Junco D; Reveille JD; Gonzalez EB; Draeger HT; Perry M; Hendiani A; Anand KK; Assassi S
    Arthritis Rheum; 2011 Feb; 63(2):530-4. PubMed ID: 21280007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors for Future Scleroderma Renal Crisis at Systemic Sclerosis Diagnosis.
    Gordon SM; Stitt RS; Nee R; Bailey WT; Little DJ; Knight KR; Hughes JB; Edison JD; Olson SW
    J Rheumatol; 2019 Jan; 46(1):85-92. PubMed ID: 30008456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serologic profile and mortality rates of scleroderma renal crisis in Italy.
    Codullo V; Cavazzana I; Bonino C; Alpini C; Cavagna L; Cozzi F; Del Papa N; Franceschini F; Guiducci S; Morozzi G; Ruffatti A; Ferri C; Giacomelli R; Matucci-Cerinic M; Valentini G; Montecucco C
    J Rheumatol; 2009 Jul; 36(7):1464-9. PubMed ID: 19487262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.
    Nikpour M; Hissaria P; Byron J; Sahhar J; Micallef M; Paspaliaris W; Roddy J; Nash P; Sturgess A; Proudman S; Stevens W
    Arthritis Res Ther; 2011; 13(6):R211. PubMed ID: 22189167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiopulmonary Disease Development in Anti-RNA Polymerase III-positive Systemic Sclerosis: Comparative Analyses from an Unselected, Prospective Patient Cohort.
    Hoffmann-Vold AM; Midtvedt Ø; Tennøe AH; Garen T; Lund MB; Aaløkken TM; Andreassen AK; Elhage F; Brunborg C; Taraldsrud E; Molberg Ø
    J Rheumatol; 2017 Apr; 44(4):459-465. PubMed ID: 28089974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scleroderma renal crisis.
    Bose N; Chiesa-Vottero A; Chatterjee S
    Semin Arthritis Rheum; 2015 Jun; 44(6):687-94. PubMed ID: 25613774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies.
    Hamaguchi Y; Kodera M; Matsushita T; Hasegawa M; Inaba Y; Usuda T; Kuwana M; Takehara K; Fujimoto M
    Arthritis Rheumatol; 2015 Apr; 67(4):1045-52. PubMed ID: 25512203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic sclerosis with renal crisis and pulmonary hypertension: a report of eleven cases.
    Gündüz OH; Fertig N; Lucas M; Medsger TA
    Arthritis Rheum; 2001 Jul; 44(7):1663-6. PubMed ID: 11465718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta-analysis.
    Xiong A; Cao Y; Xiang Q; Song Z; Zhang Y; Zhou S; Qiang Y; Chen H; Hu Z; Cui H; Luo J; Wang Y; Yang Y; Yang M; Shuai S
    J Clin Pharm Ther; 2022 Jun; 47(6):722-731. PubMed ID: 35233779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A retrospective clinical analysis of 16 patients with scleroderma renal crisis].
    Zhou J; Xu D; Hou Y; Wang Q; Li M; Zeng X
    Zhonghua Nei Ke Za Zhi; 2015 Feb; 54(2):125-9. PubMed ID: 25907843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis.
    Nihtyanova SI; Sari A; Harvey JC; Leslie A; Derrett-Smith EC; Fonseca C; Ong VH; Denton CP
    Arthritis Rheumatol; 2020 Mar; 72(3):465-476. PubMed ID: 31682743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scleroderma renal crisis: a rare but severe complication of systemic sclerosis.
    Mouthon L; Bérezné A; Bussone G; Noël LH; Villiger PM; Guillevin L
    Clin Rev Allergy Immunol; 2011 Apr; 40(2):84-91. PubMed ID: 20012923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-RNA polymerase III antibody-associated scleroderma renal crisis in a patient with limited cutaneous systemic sclerosis: A case report.
    Takada D; Hoshino J; Kikuchi K; Yabuuchi J; Kogure Y; Ueno T; Sekine A; Yamanouchi M; Sumida K; Mise K; Suwabe T; Hayami N; Sawa N; Takaichi K; Hayasi N; Fujii T; Ohashi K; Ubara Y
    Mod Rheumatol; 2018 Mar; 28(2):369-372. PubMed ID: 26942857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic sclerosis medications and risk of scleroderma renal crisis.
    Gordon SM; Hughes JB; Nee R; Stitt RS; Bailey WT; Little DJ; Edison JD; Olson SW
    BMC Nephrol; 2019 Jul; 20(1):279. PubMed ID: 31345158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial hypertension treated with angiotensin converting enzyme inhibitors and glucocorticoids are independent risk factors associated with decreased glomerular filtration rate in systemic sclerosis.
    Ostojic P; Stojanovski N
    Rheumatol Int; 2017 Mar; 37(3):363-368. PubMed ID: 28008457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Frequency of Scleroderma Renal Crisis over Time: A Metaanalysis.
    Turk M; Pope JE
    J Rheumatol; 2016 Jul; 43(7):1350-5. PubMed ID: 27134252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
    DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
    Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.